https://groupedevonian.com/devonian-bolsters-leadership-team-and-aligns-strategy-to-accelerate-clinical-development-and-drive-revenue-growth-and-commercial-success/ 2024-01-05T15:06:03+00:00 https://groupedevonian.com/devonian-files-patent-cooperation-treaty-pct-application-for-thykamine-in-wound-healing/ 2024-01-05T15:06:04+00:00 https://groupedevonian.com/devonian-health-group-receives-a-notice-of-allowance-for-issuance-of-a-u-s-patent-on-a-method-of-treatment-of-inflammatory-bowel-disease/ 2024-01-05T15:06:04+00:00 https://groupedevonian.com/devonian-announces-closing-of-a-private-placement-of-500000/ 2024-01-05T15:06:04+00:00 https://groupedevonian.com/devonian-announces-closing-of-a-private-placement-of-1-2-million/ 2024-01-05T15:06:05+00:00 https://groupedevonian.com/devonian-announces-private-placement-of-up-to-5-million/ 2024-01-05T15:06:05+00:00 https://groupedevonian.com/devonian-health-group-announces-presentation-of-thykamine-efficacy-results-in-atopic-dermatitis-at-the-world-congress-of-dermatology-and-provides-thykamine-clinical-development-progr/ 2024-01-05T15:06:05+00:00 https://groupedevonian.com/devonian-health-group-announces-voting-results-of-the-annual-general-and-special-meeting-and-welcome-new-board-members-2-2-2-2/ 2024-01-05T15:06:06+00:00 https://groupedevonian.com/devonian-health-group-announces-voting-results-of-the-annual-general-and-special-meeting-and-welcome-new-board-members-2/ 2024-01-05T15:06:06+00:00 https://groupedevonian.com/devonian-health-group-announces-voting-results-of-the-annual-general-and-special-meeting-and-welcome-new-board-members-2-2/ 2024-01-05T15:06:06+00:00 https://groupedevonian.com/devonian-health-group-announces-voting-results-of-the-annual-general-and-special-meeting-and-welcome-new-board-members-2-2-2/ 2024-01-05T15:06:06+00:00 https://groupedevonian.com/devonian-health-group-inc-to-participate-in-three-renmarks-virtual-non-deal-roadshow-series/ 2024-01-05T15:06:07+00:00 https://groupedevonian.com/devonianevonian-health-group-announces-hybrid-shareholders-annual-general-and-special-meeting/ 2024-01-05T15:06:07+00:00 https://groupedevonian.com/devonian-health-group-inc-to-participate-in-three-renmarks-virtual-non-deal-roadshow-series-2/ 2024-01-05T15:06:07+00:00 https://groupedevonian.com/devonian-health-group-announces-its-participation-at-bio-ceo-investor-conference/ 2024-01-05T15:06:07+00:00 https://groupedevonian.com/devonian-health-group-announces-peer-reviewed-publication-of-thykamine-positive-phase-2-clinical-trial-results-in-journal-of-drugs-in-dermatology/ 2024-01-05T15:06:08+00:00 https://groupedevonian.com/devonian-announces-the-issuance-of-units-in-settlement-of-interests-owed-to-debenture-holders-5/ 2024-01-05T15:06:08+00:00 https://groupedevonian.com/devonian-to-present-thykamine-phase-2-clinical-results-at-the-6th-dermatology-drug-development-summit-for-iinflammatory-skin-diseases/ 2024-01-05T15:06:08+00:00 https://groupedevonian.com/devonian-health-group-announces-trading-on-the-otcqb-market-under-symbol-dvhgf/ 2024-01-05T15:06:09+00:00 https://groupedevonian.com/devonian-announces-adoption-of-restricted-share-unit-plan/ 2024-01-05T15:06:09+00:00 https://groupedevonian.com/devonian-announces-executive-changes-grant-of-stock-options-and-settlement-of-interests-and-repayment-of-principal-amount-owed-to-a-debenture-holder/ 2024-01-05T15:06:09+00:00 https://groupedevonian.com/devonian-announces-adoption-of-restricted-share-unit-plan-2/ 2024-01-05T15:06:09+00:00 https://groupedevonian.com/devonian-announces-the-issuance-of-units-in-settlement-of-interests-owed-to-debenture-holders-4/ 2024-01-05T15:06:10+00:00 https://groupedevonian.com/devonian-announces-the-issuance-of-units-in-settlement-of-interests-owed-to-a-debenture-holder-and-grant-of-stock-options/ 2024-01-05T15:06:11+00:00 https://groupedevonian.com/devonian-health-group-announces-voting-results-of-the-annual-general-and-special-meeting-and-welcome-new-board-members/ 2024-01-05T15:06:11+00:00 https://groupedevonian.com/devonian-announces-adoption-of-shareholder-rights-plan-and-modification-to-a-private-placement/ 2024-01-05T15:06:12+00:00 https://groupedevonian.com/devonian-health-group-announces-application-for-otcqb-listing/ 2024-01-05T15:06:13+00:00 https://groupedevonian.com/devonian-health-group-announces-publication-of-article-on-potential-use-of-thykamine-in-the-treatment-of-covid-19-in-the-international-journal-of-noncommunicable-diseases/ 2024-01-05T15:06:13+00:00 https://groupedevonian.com/devonian-announces-closing-of-an-oversubscribed-private-placement-of-10000000/ 2024-01-05T15:06:14+00:00 https://groupedevonian.com/devonian-announces-the-issuance-of-subordinate-voting-shares-in-settlement-of-a-debt-owed-to-a-consultant-and-the-grant-of-stock-options/ 2024-01-05T15:06:14+00:00 https://groupedevonian.com/devonian-health-group-announces-closing-of-the-first-tranche-of-a-private-placement-of-2292199-50/ 2024-01-05T15:06:15+00:00 https://groupedevonian.com/devonian-health-group-announces-its-participation-at-bio-partnering-during-jp-morgan-healthcare-conference-2022-being-held-virtually-on-january-10-to-14-2022/ 2024-01-05T15:06:16+00:00 https://groupedevonian.com/devonian-health-group-announces-appointment-of-martin-moreau-as-vice-president-finance-and-as-a-new-member-of-its-board-of-directors/ 2024-01-05T15:06:17+00:00 https://groupedevonian.com/devonian-health-group-announces-closing-of-a-private-placement/ 2024-01-05T15:06:17+00:00 https://groupedevonian.com/devonian-announces-the-issuance-of-units-in-settlement-of-interests-owed-to-debenture-holders-3/ 2024-01-05T15:06:18+00:00 https://groupedevonian.com/devonian-health-group-inc-announces-its-participation-at-virtual-bioplus-interphex-korea-2021-to-take-place-from-august-31st-to-september-15-2021/ 2024-01-05T15:06:19+00:00 https://groupedevonian.com/devonian-announces-the-issuance-of-units-in-settlement-of-interests-owed-to-a-debenture-holder-2/ 2024-01-05T15:06:19+00:00 https://groupedevonian.com/devonian-health-group-announces-exclusive-distribution-sales-and-marketing-agreement-for-purgenesis-anti-aging-products-in-middle-east-countries/ 2024-01-05T15:06:19+00:00 https://groupedevonian.com/devonian-heath-group-inc-to-participate-in-renmarks-virtual-non-deal-roadshow-series-in-chicago-usa-today-july-27-2021/ 2024-01-05T15:06:20+00:00 https://groupedevonian.com/devonian-heath-group-inc-to-participate-in-renmarks-virtual-non-deal-roadshow-series-in-los-angeles-usa-today-july-20-2021/ 2024-01-05T15:06:20+00:00 https://groupedevonian.com/devonian-heath-group-inc-to-participate-in-renmarks-virtual-non-deal-roadshow-series-for-vancouver-today-june-14-2021/ 2024-01-05T15:06:21+00:00 https://groupedevonian.com/devonian-heath-group-inc-to-participate-in-renmarks-virtual-non-deal-roadshow-series-in-boston-usa-today-may-26-2021/ 2024-01-05T15:06:22+00:00 https://groupedevonian.com/devonian-heath-group-inc-to-participate-in-renmarks-virtual-non-deal-roadshow-series-for-montreal-and-east-of-canada-today-june-3rd-2021/ 2024-01-05T15:06:22+00:00 https://groupedevonian.com/devonian-heath-group-inc-to-present-at-the-canada-india-healthcare-summit-2021/ 2024-01-05T15:06:23+00:00 https://groupedevonian.com/devonian-health-group-inc-retains-renmark-financial-communications-inc-to-provide-investor-relations-services/ 2024-01-05T15:06:24+00:00 https://groupedevonian.com/devonian-heath-group-inc-to-participate-in-renmarks-virtual-non-deal-roadshow-series-on-thursday-may-13-2021/ 2024-01-05T15:06:24+00:00 https://groupedevonian.com/devonian-health-group-announces-notice-of-allowance-for-a-us-patent-application-covering-use-of-thykamine-for-the-treatment-of-cardiovascular-diseases/ 2024-01-05T15:06:25+00:00 https://groupedevonian.com/devonian-health-group-announces-positive-topline-results-from-phase-2-clinical-trial-of-thykamine-in-adult-patients-with-mild-to-moderate-atopic-dermatitis/ 2024-01-05T15:06:26+00:00 https://groupedevonian.com/devonian-health-group-provides-more-details-on-previously-announced-positive-topline-results-from-phase-2-clinical-trial-of-thykamine-in-adult-population-with-mild-to-moderate-atopic-dermatit/ 2024-01-05T15:06:26+00:00 https://groupedevonian.com/devonian-announces-the-issuance-of-units-in-settlement-of-interests-owed-to-debenture-holders-2/ 2024-01-05T15:06:26+00:00 https://groupedevonian.com/devonian-health-group-announces-closing-of-a-private-placement-and-the-grant-of-stock-options/ 2024-01-05T15:06:27+00:00 https://groupedevonian.com/devonian-announces-the-issuance-of-units-in-settlement-of-interests-owed-to-a-debenture-holder/ 2024-01-05T15:06:27+00:00 https://groupedevonian.com/devonian-health-group-announces-voting-results-of-the-annual-general-and-special-meeting/ 2024-01-05T15:06:27+00:00 https://groupedevonian.com/devonian-announces-correction-to-press-release-issued-july-28-2020/ 2024-01-05T15:06:28+00:00 https://groupedevonian.com/devonian-announces-the-issuance-of-units-in-settlement-of-interests-owed-to-debenture-holders/ 2024-01-05T15:06:28+00:00 https://groupedevonian.com/devonian-announces-the-issuance-of-units-in-settlement-of-interests-owed-to-a-debenture-holder-and-stock-option-grants/ 2024-01-05T15:06:28+00:00 https://groupedevonian.com/devonian-health-group-announces-completion-of-enrollment-in-its-phase-2-clinical-trial-of-thykamine-for-the-treatment-of-mild-to-moderate-atopic-dermatitis-in-adult-population/ 2024-01-05T15:06:29+00:00 https://groupedevonian.com/devonian-health-group-announces-notice-of-allowance-for-a-us-patent-application-covering-use-of-thykamine-for-the-treatment-of-ulcerative-colitis/ 2024-01-05T15:06:29+00:00 https://groupedevonian.com/devonian-health-group-announces-change-to-its-board-of-directors/ 2024-01-05T15:06:29+00:00 https://groupedevonian.com/devonian-health-group-announces-the-nomination-of-dr-andre-p-boulet-to-the-american-botanical-drug-association/ 2024-01-05T15:06:30+00:00 https://groupedevonian.com/devonian-health-group-announces-an-exclusive-strategic-alliance-with-canntx-life-sciences-for-the-development-of-cannabinoid-based-pharmaceutical-drugs/ 2024-01-05T15:06:30+00:00 https://groupedevonian.com/devonian-health-group-announces-the-closing-of-1805000-non-brokered-financing/ 2024-01-05T15:06:30+00:00 https://groupedevonian.com/devonian-health-group-announces-r-spinasome-anti-aging-technology-global-sales-and-marketing-partnership/ 2024-01-05T15:06:31+00:00 https://groupedevonian.com/devonian-health-group-announces-an-increase-to-its-non-brokered-financing-to-2000000/ 2024-01-05T15:06:31+00:00 https://groupedevonian.com/devonian-health-group-announces-the-issuance-of-securities-in-interest-settlement-due-to-debenture-holders-a-330000-non-brokered-financing-and-the-grant-of-options/ 2024-01-05T15:06:31+00:00 https://groupedevonian.com/devonian-issues-settlements-of-interest-due-to-a-debenture-holder-and-announces-the-results-of-the-annual-general-meeting-of-shareholders/ 2024-01-05T15:06:32+00:00 https://groupedevonian.com/devonian-health-group-announces-presentation-to-the-world-conference-on-ageing-and-gerontology-and-a-correction-on-expiry-date-of-warrants/ 2024-01-05T15:06:32+00:00 https://groupedevonian.com/devonian-health-group-announces-cannabis-cutting-edge-extraction-equipment-in-its-montmagny-facility/ 2024-01-05T15:06:33+00:00 https://groupedevonian.com/devonian-health-group-announces-the-publication-of-positive-results-of-the-purgenesis-anti-aging-care-clinical-study-in-the-journal-of-cosmetic-dermatology/ 2024-01-05T15:06:34+00:00 https://groupedevonian.com/devonian-health-group-announces-the-publication-of-positive-results-of-the-purgenesis-anti-aging-care-clinical-study-in-the-journal-of-cosmetic-dermatology-2/ 2024-01-05T15:06:34+00:00 https://groupedevonian.com/devonian-health-group-obtains-cannabis-research-license-from-health-canada/ 2024-01-05T15:06:34+00:00 https://groupedevonian.com/devonian-announces-the-closing-of-a-315000-private-placement-and-an-additional-loan-of-500000/ 2024-01-05T15:06:35+00:00 https://groupedevonian.com/dr-george-g-zhanel-joins-devonians-cannabinoids-scientific-advisory-board/ 2024-01-05T15:06:35+00:00 https://groupedevonian.com/devonian-announces-the-filing-of-a-new-patent-application-related-to-use-of-thylakoids-as-delivery-system-for-cannabinoids-and-other-liposoluble-molecules/ 2024-01-05T15:06:35+00:00 https://groupedevonian.com/devonian-health-group-announces-the-formation-of-a-scientific-advisory-board-with-mandate-to-assist-in-the-development-of-cannabinoids-based-pharmaceutical-products-2/ 2024-01-05T15:06:36+00:00 https://groupedevonian.com/devonian-health-group-announces-the-formation-of-a-scientific-advisory-board-with-mandate-to-assist-in-the-development-of-cannabinoids-based-pharmaceutical-products/ 2024-01-05T15:06:36+00:00 https://groupedevonian.com/devonian-health-group-announces-the-publication-of-results-of-in-vitro-assessment-of-the-antioxidant-and-uv-protection-properties-of-thylakoid-extracts-in-journal-of-cosmetic-dermatology/ 2024-01-05T15:06:36+00:00 https://groupedevonian.com/devonian-healthcare-group-reports-key-financial-results-for-quarter-ended-january-31-2019-2/ 2024-01-05T15:06:37+00:00 https://groupedevonian.com/devonian-announces-voting-results-of-the-annual-general-and-special-meeting/ 2024-01-05T15:06:37+00:00 https://groupedevonian.com/devonian-healthcare-group-reports-key-financial-results-for-quarter-ended-january-31-2019/ 2024-01-05T15:06:37+00:00 https://groupedevonian.com/devonian-health-group-announces-2018-annual-general-shareholders-meeting/ 2024-01-05T15:06:38+00:00 https://groupedevonian.com/devonian-health-group-announces-the-refinancing-of-the-loan-on-its-pharmaceutical-facility/ 2024-01-05T15:06:38+00:00 https://groupedevonian.com/devonian-health-group-provides-an-update-on-its-phase-2-clinical-study-in-atopic-dermatitis-and-announces-plans-for-the-first-photoprotection-product-issued-from-its-cosmeceutical-rd-program/ 2024-01-05T15:06:38+00:00 https://groupedevonian.com/devonian-health-group-announces-the-recognition-of-sybil-dahan-president-of-altius-healthcare-as-inductee-into-the-2018-canadian-healthcare-marketing-hall-of-fame/ 2024-01-05T15:06:39+00:00 https://groupedevonian.com/devonian-health-group-receives-2018-best-anti-aging-skin-treatment-technology-from-lux-life-magazine/ 2024-01-05T15:06:39+00:00 https://groupedevonian.com/devonian-health-group-provides-an-update-on-its-previously-announced-private-placement/ 2024-01-05T15:06:40+00:00 https://groupedevonian.com/devonian-health-group-announces-the-completion-of-the-second-tranche-of-its-previously-announced-private-placement-and-provides-an-update/ 2024-01-05T15:06:40+00:00 https://groupedevonian.com/devonian-health-group-announces-non-brokered-financing-by-way-of-a-private-placement-of-convertible-debenture/ 2024-01-05T15:06:41+00:00 https://groupedevonian.com/devonian-health-group-announces-issuance-of-european-patent-for-its-purgenesis-anti-aging-treatment/ 2024-01-05T15:06:41+00:00 https://groupedevonian.com/devonian-announces-grant-of-options-2/ 2024-01-05T15:06:42+00:00 https://groupedevonian.com/devonian-announces-the-signing-of-a-non-binding-letter-of-intent-with-folia-biotech-to-develop-fb-631-in-cancer-immunotherapy/ 2024-01-05T15:06:42+00:00 https://groupedevonian.com/devonian-healthcare-group-reports-its-first-ever-revenues-key-financial-results-for-quarter-ended-april-30th-2018/ 2024-01-05T15:06:42+00:00 https://groupedevonian.com/purgenesis-commercializing-a-skin-care-revolution/ 2024-01-05T15:06:43+00:00 https://groupedevonian.com/wp-content/uploads/2018/06/new-post-2.png https://groupedevonian.com/devonian-health-group-announce-the-commercial-launch-of-the-purgenesis-anti-aging-treatment-at-the-canadian-dermatology-association-s-annual-conference/ 2024-01-05T15:06:43+00:00 https://groupedevonian.com/devonian-health-group-announces-issuance-of-united-states-patent-for-its-purgenesis-anti-aging-treatment/ 2024-01-05T15:06:43+00:00 https://groupedevonian.com/devonian-announces-trading-shares-will-resume-tuesday-february-27th-2018/ 2024-01-05T15:06:44+00:00 https://groupedevonian.com/devonian-health-group-announces-canadian-patent-for-its-purgenesis-anti-aging-treatment/ 2024-01-05T15:06:44+00:00 https://groupedevonian.com/devonian-announces-grant-of-options/ 2024-01-05T15:06:44+00:00 https://groupedevonian.com/devonian-announces-acquisition-altius-healthcare/ 2024-01-05T15:06:45+00:00 https://groupedevonian.com/devonian-announces-voting-results-annual-general-special-meeting/ 2024-01-05T15:06:45+00:00 https://groupedevonian.com/devonian-announces-voting-results-annual-general-special-meeting/ 2024-01-05T15:06:45+00:00 https://groupedevonian.com/devonian-health-group-present-gcff-global-chinese-financial-conference-18th-annual-conference/ 2024-01-05T15:06:46+00:00 https://groupedevonian.com/devonian-announces-initiation-phase-iia-clinical-trial-thykaminetm-adult-patients-mild-moderate-atopic-dermatitis/ 2024-01-05T15:06:46+00:00 https://groupedevonian.com/devonian-announces-filing-new-patent-application-thykaminetm/ 2024-01-05T15:06:46+00:00 https://groupedevonian.com/devonian-health-announces-purgenesistm-anti-aging-treatment-marketing-distribution-partnership/ 2024-01-05T15:06:46+00:00 https://groupedevonian.com/2580/ 2024-01-05T15:06:47+00:00 https://groupedevonian.com/devonian-health-group-inc-devonian-announces-grant-options/ 2024-01-05T15:06:47+00:00 https://groupedevonian.com/devonian-health-group-inc-devonian-announces-closing-private-placement/ 2024-01-05T15:06:47+00:00 https://groupedevonian.com/devonian-health-group-inc-listing-shares-tsx-venture-exchange/ 2024-01-05T15:06:48+00:00 https://groupedevonian.com/devonian-health-group-inc-devonian-announces-appointment-two-new-members-board-directors-senior-management-changes-support-growth-strategy/ 2024-01-05T15:06:48+00:00 https://groupedevonian.com/devonian-health-group-inc-devonian-announces-issuance-one-new-key-patent-granting-trademark/ 2024-01-05T15:06:48+00:00 https://groupedevonian.com/devonian-health-group-inc-devonian-announces-plans-dermatology-program-thykamine/ 2024-01-05T15:06:48+00:00 https://groupedevonian.com/orletto-capital-inc-devonian-health-group-inc-results-votes-annual-general-meeting-orletto/ 2024-01-05T15:06:49+00:00 https://groupedevonian.com/orletto-capital-inc-devonian-health-group-inc-receipt-amended-restated-prospectus/ 2024-01-05T15:06:49+00:00 https://groupedevonian.com/orletto-capital-inc-devonian-health-group-inc-completion-amalgamation-closing-concurent-public-offering/ 2024-01-05T15:06:49+00:00 https://groupedevonian.com/orletto-capital-inc-devonian-health-group-inc-end-previously-announced-public-offering/ 2024-01-05T15:06:49+00:00 https://groupedevonian.com/orletto-capital-inc-devonian-health-group-inc-results-votes-annual-general-meeting-devonian/ 2024-01-05T15:06:49+00:00 https://groupedevonian.com/orletto-capital-inc-devonian-health-group-inc-agreement-principle/ 2024-01-05T15:06:50+00:00 https://groupedevonian.com/orletto-capital-inc-devonian-health-group-inc-agreement-principle-2/ 2024-01-05T15:06:50+00:00 https://groupedevonian.com/orletto-capital-inc-devonian-health-group-inc-financing-way-long-form-prospectus/ 2024-01-05T15:06:50+00:00 https://groupedevonian.com/orletto-capital-inc-devonian-health-group-inc-devonian-appoints-dr-jean-claude-tardif-chairman-scientific-advisory-board/ 2024-01-05T15:06:50+00:00 https://groupedevonian.com/fr/devonian-annonce-la-cloture-dun-placement-prive-de-500-000-2/ 2024-01-05T15:07:12+00:00 https://groupedevonian.com/fr/devonian-renforce-son-equipe-de-direction-et-coordonne-sa-strategie-afin-daccelerer-son-developpement-clinique-stimuler-la-croissance-de-son-chiffre-daffaires-et-assurer-son-succes-commercial/ 2024-01-05T15:07:12+00:00 https://groupedevonian.com/fr/devonian-annonce-la-cloture-dun-placement-prive-de-12-million/ 2024-01-05T15:07:13+00:00 https://groupedevonian.com/fr/devonian-annonce-la-cloture-dun-placement-prive-de-12-million-2/ 2024-01-05T15:07:13+00:00 https://groupedevonian.com/fr/devonian-annonce-la-cloture-dun-placement-prive-de-500-000/ 2024-01-05T15:07:13+00:00 https://groupedevonian.com/fr/devonian-annonce-le-depot-dun-prospectus-prealable-de-base-provisoire/ 2024-01-05T15:07:14+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-annonce-la-nomination-de-nouveaux-membres-au-conseil-dadministration-et-lattribution-doptions-dachat-dactions/ 2024-01-05T15:07:14+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-annonce-la-presentation-des-resultats-defficacite-du-thykamine-en-dermatite-atopique-au-congres-mondial-de-dermatologie-et-fournit-une-mise-a-jour-du-programme/ 2024-01-05T15:07:14+00:00 https://groupedevonian.com/fr/devonian-annonce-un-placement-prive-dun-montant-maximum-de-5-millions/ 2024-01-05T15:07:14+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-annonce-les-resultats-de-lassemblee-generale-annuelle-et-extraordinaire-des-actionnaires-et-accueille-des-nouveaux-membres-au-conseil-dadministration/ 2024-01-05T15:07:15+00:00 https://groupedevonian.com/fr/devonian-annonce-lapprobation-de-modifications-a-son-regime-doptions-dachat-dactions-et-a-son-regime-dunites-dactions-assujetties-a-des-restrictio/ 2024-01-05T15:07:15+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-annonce-de-la-reunion-annuelle-generale-et-speciale-des-actionnaires-en-format-hybride/ 2024-01-05T15:07:15+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-annonce-des-changements-au-sein-de-la-direction-et-loctroi-doptions-dachat-dactions/ 2024-01-05T15:07:16+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-annonce-sa-participation-a-bio-ceo-investor-conference/ 2024-01-05T15:07:16+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-annonce-sa-participation-a-trois-evenements-de-la-serie-de-tournees-virtuelles-sans-transaction-de-renmark/ 2024-01-05T15:07:16+00:00 https://groupedevonian.com/fr/devonian-presentera-les-resulats-cliniques-de-la-phase-2-du-thykamine-au-6th-dermatology-drug-development-summit-for-inflammatory-skin-diseases/ 2024-01-05T15:07:17+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-annonce-la-publication-a-comite-de-lecture-des-resultats-positifs-de-lessai-clinique-de-phase-2-du-thykaminemc-dans-le-journal-of-drugs-in-dermatology/ 2024-01-05T15:07:17+00:00 https://groupedevonian.com/fr/devonian-annonce-lemission-dunites-en-reglement-des-interets-dus-a-des-detenteurs-de-debentures-5/ 2024-01-05T15:07:17+00:00 https://groupedevonian.com/fr/devonian-annonce-ladoption-dun-regime-dunites-dactions-assujetties-a-des-restrictions/ 2024-01-05T15:07:18+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-annonce-la-negociation-de-ses-actions-sur-le-marche-otcqb-sous-le-symbole-dvhgf/ 2024-01-05T15:07:18+00:00 https://groupedevonian.com/fr/devonian-annonce-des-changements-a-la-direction-loctroi-doptions-dachat-dactions-et-le-reglement-du-capital-et-des-interets-dus-a-un-detenteur-de-debenture/ 2024-01-05T15:07:18+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-annonce-lacceptation-par-le-journal-of-drugs-in-dermatology-de-la-publication-des-resultats-positifs-de-lessai-clinique-de-phase-2-en-dermatite-atopique-du-thykaminemc/ 2024-01-05T15:07:18+00:00 https://groupedevonian.com/fr/devonian-annonce-lemission-dunites-en-reglement-des-interets-dus-a-des-detenteurs-de-debentures-4/ 2024-01-05T15:07:19+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-annonce-les-resultats-de-lassemblee-generale-annuelle-et-extraordinaire-des-actionnaires-et-accueilles-des-nouveaux-membres-au-conseil-dadministration/ 2024-01-05T15:07:19+00:00 https://groupedevonian.com/fr/devonian-annonce-lemission-dunites-en-reglement-des-interets-dus-a-un-detenteur-de-debentures-et-loctroi-doptions-dachat-dactions-2/ 2024-01-05T15:07:20+00:00 https://groupedevonian.com/fr/devonian-annonce-ladoption-dun-regime-de-droits-des-actionnaires-et-la-modification-dun-placement-prive/ 2024-01-05T15:07:20+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-annonce-la-demande-dinscription-sur-otcqb/ 2024-01-05T15:07:20+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-annonce-la-publication-dun-article-sur-lutilisation-potentielle-du-thykaminemc-pour-le-traitement-de-la-covid-19-dans-international-journal-of-noncommunicable-diseases/ 2024-01-05T15:07:21+00:00 https://groupedevonian.com/fr/devonian-annonce-la-cloture-dun-placement-prive-sursouscrit-de-10-000-000/ 2024-01-05T15:07:22+00:00 https://groupedevonian.com/fr/devonian-annonce-lemission-dactions-a-droit-de-vote-subalterne-en-reglement-dune-dette-due-a-un-consultant-et-loctroi-doptions-dachat-dac/ 2024-01-05T15:07:22+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-annonce-la-cloture-dune-premiere-tranche-dun-placement-prive-de-2-292-19950/ 2024-01-05T15:07:23+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-annonce-sa-participation-a-bio-partening-lors-de-la-conference-annuelle-de-jp-morgan-healthcare-2022-qui-se-tiendra-virtuellement-du-10-au-14-janvier-2022/ 2024-01-05T15:07:23+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-annonce-la-cloture-dun-placement-prive/ 2024-01-05T15:07:24+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-annonce-la-nomination-de-martin-moreau-au-poste-de-vice-president-finances-et-comme-nouveau-membre-de-son-conseil-dadministration/ 2024-01-05T15:07:24+00:00 https://groupedevonian.com/fr/devonian-annonce-lemission-dunites-en-reglement-des-interets-dus-a-des-detenteurs-de-debentures-3/ 2024-01-05T15:07:25+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-annonce-un-accord-exclusif-de-distribution-de-vente-et-de-commercialisation-pour-les-produits-anti-age-purgenesismc-dans-les-pays-du-moyen-orient/ 2024-01-05T15:07:25+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-annonce-sa-participation-a-la-conference-annuelle-bioplus-interphex-korea-2021-qui-aura-lieu-du-31-aout-au-15-septembre-2021/ 2024-01-05T15:07:26+00:00 https://groupedevonian.com/fr/devonian-annonce-lemission-dunites-en-reglement-des-interets-dus-a-un-detenteur-de-debentures-2/ 2024-01-05T15:07:26+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-annonce-sa-participation-aux-series-vndr-de-renmark-pour-chicago-aujourdhui-le-27-juillet-2021/ 2024-01-05T15:07:27+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-annonce-sa-participation-aux-series-vndr-de-renmark-pour-los-angeles-aujourdhui-le-20-juillet-2021/ 2024-01-05T15:07:27+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-annonce-sa-participation-aux-series-vndr-de-renmark-pour-vancouver-aujourdhui-le-14-juin-2021/ 2024-01-05T15:07:28+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-annonce-sa-participation-aux-series-vndr-de-renmark-pour-montreal-et-lest-du-canada-aujourdhui-le-3-juin-2021/ 2024-01-05T15:07:29+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-annonce-sa-participation-aux-series-vndr-de-renmark-a-boston-etats-unis-aujourdhui-26-mai-2021/ 2024-01-05T15:07:29+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-annonce-sa-participation-aux-series-vndr-de-renmark-le-jeudi-13-mai-2021/ 2024-01-05T15:07:30+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-inc-to-presente-au-sommet-de-la-sante-canada-inde-2021/ 2024-01-05T15:07:30+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-annonce-un-avis-dadmission-pour-une-demande-de-brevet-americain-concernant-lutilisation-de-thykaminemc-pour-le-traitement-de-maladies-cardiovasculaires/ 2024-01-05T15:07:31+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-inc-selectionne-renmark-financial-communications-inc-pour-les-relations-avec-les-investisseurs/ 2024-01-05T15:07:31+00:00 https://groupedevonian.com/fr/devonian-annonce-lemission-dunites-en-reglement-des-interets-dus-a-des-detenteurs-de-debentures-2/ 2024-01-05T15:07:32+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-fournit-plus-de-details-sur-les-resultats-positifs-precedemment-annonces-de-lessai-clinique-de-phase-2-du-thykaminemc-et-loctroi-doptions-dachat-dactions/ 2024-01-05T15:07:32+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-annonce-les-resultats-de-lassemblee-generale-annuelle-et-extraordinaire-des-actionnaires-2/ 2024-01-05T15:07:33+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-annonce-les-resultats-positifs-de-lessai-clinique-de-phase-2-du-thykaminemc-pour-le-traitement-de-la-dermatite-atopique-legere-a-moderee-chez-la-population-adulte/ 2024-01-05T15:07:33+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-annonce-la-cloture-dun-placement-prive-et-loctroi-doptions-dachat-dactions/ 2024-01-05T15:07:34+00:00 https://groupedevonian.com/fr/devonian-annonce-lemission-dunites-en-reglement-des-interets-dus-a-un-detenteur-de-debentures/ 2024-01-05T15:07:34+00:00 https://groupedevonian.com/fr/devonian-annonce-une-correction-relative-au-communique-de-presse-emis-le-28-juillet-2020/ 2024-01-05T15:07:35+00:00 https://groupedevonian.com/fr/devonian-annonce-lemission-dunites-en-reglement-des-interets-dus-a-des-detenteurs-de-debentures/ 2024-01-05T15:07:35+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-annonce-un-avis-dadmission-pour-une-demande-de-brevet-americain-concernant-lutilisation-de-thykamine-pour-le-traitement-de-la-colite-ulcereuse/ 2024-01-05T15:07:36+00:00 https://groupedevonian.com/fr/devonian-annonce-lemission-dunites-en-reglement-des-interets-dus-a-un-detenteur-de-debentures-et-loctroi-doptions-dachat-dactions/ 2024-01-05T15:07:36+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-annonce-un-changement-a-son-conseil-dadministration/ 2024-01-05T15:07:37+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-annonce-la-finalisation-du-recrutement-pour-son-etude-clinique-de-phase-2-du-thykaminemc-pour-le-traitement-de-la-dermatite-atopique-legere-a-moderee-chez-la-population-adulte/ 2024-01-05T15:07:37+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-annonce-la-nomination-du-dr-andre-p-boulet-a-lamerican-botanical-drug-association/ 2024-01-05T15:07:38+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-annonce-une-alliance-strategique-exclusive-avec-canntx-life-sciences-pour-le-developpement-de-medicaments-pharmaceutiques-de-classe-mondiale-a-base-de-cannabinoides/ 2024-01-05T15:07:38+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-annonce-une-augmentation-de-son-financement-sans-courtier-a-2-000-000/ 2024-01-05T15:07:39+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-annonce-la-cloture-dun-financement-prive-sans-courtier-de-1-805-000/ 2024-01-05T15:07:39+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-annonce-un-partenariat-mondial-de-vente-et-de-marketing-pour-la-technologie-anti-age-r-spinasome/ 2024-01-05T15:07:40+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-annonce-lemission-de-titres-en-reglement-des-interets-dus-aux-detenteurs-de-debentures-un-financement-sans-courtier-de-330-000-et-loctroi-doptions/ 2024-01-05T15:07:40+00:00 https://groupedevonian.com/fr/devonian-emet-des-titres-en-reglement-des-interets-dus-a-un-detenteur-de-debentures-et-annonce-les-resultats-de-lassemblee-annuelle-generale-des-actionnaires/ 2024-01-05T15:07:41+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-annonce-la-mise-en-place-dun-equipement-dextraction-de-cannabis-de-pointe-dans-son-usine-de-montmagny/ 2024-01-05T15:07:42+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-annonce-une-presentation-a-la-conference-mondiale-sur-le-vieillissement-et-la-gerontologie-et-apporte-une-correction-a-la-date-dexpiration-de-bons-de-souscription/ 2024-01-05T15:07:42+00:00 https://groupedevonian.com/fr/devonian-annonce-la-prolongation-de-son-placement-prive/ 2024-01-05T15:07:43+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-obtient-une-licence-de-recherche-sur-le-cannabis-de-sante-canada/ 2024-01-05T15:07:43+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-annonce-la-publication-des-resultats-positifs-de-letude-clinique-sur-les-soins-anti-age-purgenesis-dans-le-journal-of-cosmetic-dermatology/ 2024-01-05T15:07:44+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-annonce-la-creation-dun-conseil-consultatif-de-dermatologie-clinique-ayant-pour-mandat-de-contribuer-au-developpement-de-produits-pharmaceutiques-a-base-de-cannabinoides/ 2024-01-05T15:07:44+00:00 https://groupedevonian.com/fr/devonian-complete-un-placement-prive-de-315-000-et-obtient-un-pret-additionnel-de-500-000/ 2024-01-05T15:07:45+00:00 https://groupedevonian.com/fr/devonian-signe-une-lettre-dintention-contraignante-avec-histapharm-inc-visant-lextraction-et-de-la-fabrication-de-leur-produit-pharmaceutique-botanique-ainsi-quun-partenariat-strategique-2/ 2024-01-05T15:07:46+00:00 https://groupedevonian.com/fr/dr-george-g-zhanel-se-joint-au-comite-consultatif-scientifique-des-cannabinoides-de-devonian/ 2024-01-05T15:07:46+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-annonce-la-creation-dun-conseil-consultatif-scientifique-ayant-pour-mandat-de-contribuer-au-developpement-de-produits-pharmaceutiques-a-base-de-cannabinoides/ 2024-01-05T15:07:47+00:00 https://groupedevonian.com/fr/devonian-signe-une-lettre-dintention-contraignante-avec-histapharm-inc-visant-lextraction-et-de-la-fabrication-de-leur-produit-pharmaceutique-botanique-ainsi-quun-partenariat-strategique/ 2024-01-05T15:07:47+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-rapporte-ses-resultats-financiers-cles-pour-le-trimestre-termine-le-31-janvier-2019/ 2024-01-05T15:07:48+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-annonce-la-publication-des-resultats-de-levaluation-in-vitro-des-proprietes-antioxydantes-et-de-protection-uv-des-extraits-de-thylakoides-dans-journal-of-cosmetic-dermatology/ 2024-01-05T15:07:48+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-annonce-les-resultats-de-lassemblee-generale-annuelle-et-extraordinaire-des-actionnaires/ 2024-01-05T15:07:49+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-rapporte-ses-resultats-financiers-cles-pour-le-trimestre-termine-le-31-janvier-2019-2/ 2024-01-05T15:07:49+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-annonce-le-refinancement-du-pret-pour-ses-installations-pharmaceutiques/ 2024-01-05T15:07:50+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-fournit-une-mise-a-jour-de-son-etude-clinique-de-phase-2-en-dermatite-atopique-et-annonce-son-programme-pour-le-premier-produit-de-photoprotection-issu-de-son-programme-de-recher/ 2024-01-05T15:07:50+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-annonce-la-tenue-de-son-assemblee-generale-annuelle-des-actionnaires-pour-2018/ 2024-01-05T15:07:51+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-annonce-lintronisation-de-sybil-dahan-presidente-daltius-healthcare-au-temple-de-la-renommee-canadien-2018-du-marketing-des-soins-de-sante/ 2024-01-05T15:07:51+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-recoit-le-prix-2018-de-la-meilleure-technologie-anti-age-decerne-par-lux-life-magazine/ 2024-01-05T15:07:52+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-annonce-la-cloture-de-la-seconde-tranche-de-son-placement-prive-prealablement-annonce-et-fournit-une-mise-a-jour/ 2024-01-05T15:07:52+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-recoit-lavis-dacceptation-pour-le-brevet-europeen-de-son-traitement-anti-age-purgenesis-mc/ 2024-01-05T15:07:53+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-fournit-une-mise-a-jour-sur-son-placement-prive-prealablement-annonce/ 2024-01-05T15:07:53+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-rapporte-ses-premiers-revenus-resultats-financiers-cles-pour-le-trimestre-termine-le-30-avril-2018/ 2024-01-05T15:07:54+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-annonce-un-financement-prive-sans-syndicat-de-courtiers-de-debentures-convertibles/ 2024-01-05T15:07:54+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-annonce-la-signature-d-une-lettre-d-intention-non-contraignante-avec-folia-biotech-pour-le-developpement-du-fb-631-en-immunotherapie-pour-le-cancer/ 2024-01-05T15:07:55+00:00 https://groupedevonian.com/fr/devonian-annonce-l-octroi-d-options/ 2024-01-05T15:07:55+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-annonce-le-lancement-commercial-du-traitement-anti-age-purgenesis-a-la-conference-annuelle-de-l-association-canadienne-de-dermatologie/ 2024-01-05T15:07:56+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-recoit-lavis-dacceptation-pour-le-brevet-americain-de-son-traitement-anti-age-purgenesismc/ 2024-01-05T15:07:56+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-recoit-lavis-dacceptation-pour-le-brevet-canadien-de-son-traitement-anti-age-purgenesis-mc/ 2024-01-05T15:07:57+00:00 https://groupedevonian.com/fr/purgenesis-commercializing-a-skin-care-revolution/ 2024-01-05T15:07:57+00:00 https://groupedevonian.com/wp-content/uploads/2018/06/new-post-2.png https://groupedevonian.com/fr/devonian-annonce-que-la-negociation-de-ses-actions-reprendra-le-mardi-27-fevrier-2018/ 2024-01-05T15:07:58+00:00 https://groupedevonian.com/fr/devonian-annonce-loctroi-doptions/ 2024-01-05T15:07:58+00:00 https://groupedevonian.com/fr/devonian-annonce-lacquisition-de-altius-healthcare/ 2024-01-05T15:07:59+00:00 https://groupedevonian.com/fr/aspri-pharma-canada-inc-announces-acquisition-subordinate-voting-shares-devonian-health-group-inc-version-anglaise-seulement/ 2024-01-05T15:07:59+00:00 https://groupedevonian.com/fr/devonian-annonce-le-depot-dune-nouvelle-demande-de-brevet-pour-le-thykaminemc/ 2024-01-05T15:08:00+00:00 https://groupedevonian.com/fr/devonian-annonce-les-resultats-de-lassemblee-generale-annuelle-et-extraordinaire-des-actionnaires/ 2024-01-05T15:08:00+00:00 https://groupedevonian.com/fr/devonian-annonce-linitiation-de-letude-clinique-de-phase-iia-du-thykaminemc-chez-les-patients-atteints-de-dermatite-atopique-legere-moderee/ 2024-01-05T15:08:01+00:00 https://groupedevonian.com/fr/devonian-annonce-un-partenariat-de-commercialisation-et-de-distribution-du-traitement-anti-age-purgenesis-mc/ 2024-01-05T15:08:01+00:00 https://groupedevonian.com/fr/2584/ 2024-01-05T15:08:02+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-presentera-la-18e-conference-annuelle-de-la-gcff-global-chinese-financial-conference/ 2024-01-05T15:08:02+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-inc-devonian-annonce-la-cloture-dun-placement-prive/ 2024-01-05T15:08:03+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-inc-devonian-annonce-loctroi-doptions/ 2024-01-05T15:08:03+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-inc-devonian-annonce-ses-plans-pour-son-programme-en-dermatologie-du-thykamine/ 2024-01-05T15:08:04+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-inc-devonian-annonce-la-deliverance-dun-nouveau-brevet-cle-et-loctroi-dune-marque-de-commerce/ 2024-01-05T15:08:04+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-inc-devonian-annonce-la-nomination-de-deux-nouveaux-membres-son-conseil-dadministration-ainsi-que-des-changements-la-haute-direction-afin-de-soutenir-la-strategie/ 2024-01-05T15:08:05+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-inc-debut-de-la-negotiation-de-ses-actions-la-bourse-de-croissance-tsx/ 2024-01-05T15:08:06+00:00 https://groupedevonian.com/fr/capital-orletto-inc-groupe-sante-devonian-inc-cloture-de-la-fusion-et-cloture-dun-appel-public-lepargne-concomitant/ 2024-01-05T15:08:06+00:00 https://groupedevonian.com/fr/capital-orletto-inc-groupe-sante-devonian-inc-fin-de-son-placement-public-prealablement-annonce/ 2024-01-05T15:08:07+00:00 https://groupedevonian.com/fr/capital-orletto-inc-groupe-sante-devonian-inc-obtention-du-visa-pour-la-version-modifiee-de-son-prospectus/ 2024-01-05T15:08:07+00:00 https://groupedevonian.com/fr/capital-orletto-inc-groupe-sante-devonian-inc-resultats-des-votes-lors-de-lassemblee-generale-annuelle-dorletto/ 2024-01-05T15:08:07+00:00 https://groupedevonian.com/fr/capital-orletto-inc-groupe-sante-devonian-inc-resultats-des-votes-lors-de-lassemblee-generale-annuelle-de-devonian/ 2024-01-05T15:08:08+00:00 https://groupedevonian.com/fr/capital-orletto-inc-groupe-sante-devonian-inc-devonian-nomme-dr-jean-claude-tardif-president-du-comite-aviseur-scientifique/ 2024-01-05T15:08:08+00:00 https://groupedevonian.com/fr/capital-orletto-inc-groupe-sante-devonian-inc-financement-par-voie-de-prospectus/ 2024-01-05T15:08:09+00:00 https://groupedevonian.com/fr/orletto-capital-inc-devonian-health-group-inc-agreement-principle-2/ 2024-01-05T15:08:09+00:00 https://groupedevonian.com/fr/orletto-capital-inc-devonian-health-group-inc-agreement-principle/ 2024-01-05T15:08:10+00:00 https://groupedevonian.com/devonian-seeks-shareholders-approval-for-share-consolidation/ 2024-02-02T17:17:27+00:00 https://groupedevonian.com/fr/devonian-demande-lapprobation-des-actionnaires-pour-un-regroupement-dactions/ 2024-02-09T17:48:22+00:00 https://groupedevonian.com/devonian-bolsters-intellectual-property-with-issuance-of-u-s-patent-covering-a-method-of-treatment-of-inflammatory-bowel-disease/ 2024-02-20T18:31:27+00:00 https://groupedevonian.com/fr/devonian-demande-lapprobation-des-actionnaires-pour-un-regroupement-dactions-2/ 2024-02-21T18:21:49+00:00 https://groupedevonian.com/devonian-announces-the-results-of-its-annual-general-and-special-shareholders-meeting-the-approval-of-amendments-to-its-stock-option-plan-and-grant-of-stock-options/ 2024-02-21T21:08:33+00:00 https://groupedevonian.com/fr/devonian-annonce-les-resultats-de-son-assemblee-generale-annuelle-et-extraordinaire-des-actionnaires-lapprobation-de-modifications-a-son-regime-doptions-dachat-dac/ 2024-02-21T21:11:15+00:00 https://groupedevonian.com/fr/devonian-annonce-un-pret-a-terme-garantie-de-216-million-suivant-le-remboursement-dun-pret-a-long-terme-de-35-million/ 2024-02-27T17:15:37+00:00 https://groupedevonian.com/devonian-announces-a-2-16-million-secured-term-loan-following-repayment-of-3-5-million-long-term-loan/ 2024-02-27T17:15:48+00:00 https://groupedevonian.com/devonian-announces-that-its-subsidiary-altius-launches-authorized-generic-of-dexlansoprazole-dexilant-in-canada/ 2024-02-27T19:21:02+00:00 https://groupedevonian.com/fr/devonian-annonce-que-sa-filiale-altius-lance-un-generique-autorise-du-dexlansoprazole-dexilant-au-canada/ 2024-02-27T19:23:02+00:00 https://groupedevonian.com/devonian-names-kathryn-j-gregory-to-the-board-of-directors-and-grants-stock-options/ 2024-02-29T18:46:53+00:00 https://groupedevonian.com/fr/devonian-nomme-kathryn-j-gregory-sur-son-conseil-dadministration-et-octroi-des-options-dachat-dactions/ 2024-02-29T18:50:06+00:00 https://groupedevonian.com/devonian-announces-closing-of-a-private-placement-of-units/ 2024-03-14T13:06:22+00:00 https://groupedevonian.com/fr/devonian-annonce-la-cloture-dun-placement-prive-dunites/ 2024-03-14T13:16:48+00:00 https://groupedevonian.com/devonian-health-group-reports-second-quarter-2024-financial-results-and-business-update/ 2024-03-28T15:19:44+00:00 https://groupedevonian.com/fr/devonian-nomme-andre-p-boulet-president-du-conseil-dadministration-et-chef-des-operations/ 2024-06-04T15:46:58+00:00 https://groupedevonian.com/devonian-appoints-andre-p-boulet-to-chairman-of-the-board-and-chief-operating-officer/ 2024-06-04T15:47:27+00:00 https://groupedevonian.com/devonian-health-group-reports-third-quarter-2024-financial-results-and-business-update-and-announces-engagement-of-investor-relations-firm/ 2024-06-25T20:15:04+00:00 https://groupedevonian.com/devonian-health-group-to-participate-in-renmarks-boston-virtual-non-deal-roadshow-series-on-wednesday-june-26-2024/ 2024-07-13T14:16:03+00:00 https://groupedevonian.com/devonian-health-group-to-participate-in-renmarks-chicago-virtual-non-deal-roadshow-series-on-wednesday-july-17-2024/ 2024-07-15T14:15:51+00:00 https://groupedevonian.com/devonian-health-group-to-participate-in-renmarks-los-angeles-virtual-non-deal-roadshow-series-on-wednesday-july-10-2024/ 2024-07-15T14:30:31+00:00 https://groupedevonian.com/fr/devonian-annonce-la-modification-de-ses-statuts-de-fusion-et-la-demission-de-la-cheffe-de-la-direction-financiere-interimaire/ 2024-10-10T21:29:29+00:00 https://groupedevonian.com/devonian-announces-amendment-to-its-articles-of-amalgamation-and-resignation-of-its-interim-chief-financial-officer/ 2024-10-10T21:31:10+00:00 https://groupedevonian.com/devonian-announces-the-grant-of-stock-options/ 2024-10-10T21:37:57+00:00 https://groupedevonian.com/fr/devonian-annonce-loctroi-doptions-dachat-dactions/ 2024-10-10T21:49:26+00:00 https://groupedevonian.com/devonian-health-group-reports-first-quarter-2025-financial-results-and-grants-stock-options/ 2024-12-24T17:55:04+00:00 https://groupedevonian.com/devonian-reports-its-annual-2024-financial-results/ 2024-12-24T17:55:13+00:00 https://groupedevonian.com/fr/devonian-publie-ses-etats-financiers-annuels-2024/ 2025-01-21T16:34:15+00:00 https://groupedevonian.com/devonian-appoints-viktoria-krasteva-as-chief-financial-officer/ 2025-01-21T16:45:34+00:00 https://groupedevonian.com/fr/devonian-nomme-viktoria-krasteva-a-titre-de-cheffe-de-la-direction-financiere/ 2025-01-21T16:46:27+00:00 https://groupedevonian.com/devonian-health-group-inc-reports-superior-anti-inflammatory-potency-of-thykamine-in-comparative-in-vitro-study/ 2025-02-11T17:04:11+00:00 https://groupedevonian.com/devonian-reports-distribution-agreement-termination/ 2025-02-11T18:45:40+00:00 https://groupedevonian.com/devonian-reports-positive-results-in-mash-liver-study/ 2025-02-13T18:38:04+00:00 https://groupedevonian.com/fr/devonian-annonce-des-resultats-positifs-dans-une-etude-sur-la-maladie-du-foie-mash/ 2025-02-13T18:38:56+00:00 https://groupedevonian.com/devonian-announces-the-filing-of-a-new-provisional-patent-application-relating-to-the-use-of-thykamine-for-treating-mash/ 2025-02-13T18:54:46+00:00 https://groupedevonian.com/fr/devonian-annonce-le-depot-dune-nouvelle-demande-de-brevet-provisoire-relative-a-lutilisation-de-thykamine-pour-le-traitement-de-la-steato-hepatite-metabolique-mash/ 2025-02-13T18:55:40+00:00 https://groupedevonian.com/devonian-announces-positive-in-vivo-results-of-thykamine-on-gene-expression-associated-with-fibrosis/ 2025-02-18T14:12:42+00:00 https://groupedevonian.com/fr/devonian-annonce-le-depot-dune-nouvelle-demande-de-brevet-provisoire-relative-a-lutilisation-de-thykamine-pour-le-traitement-de-la-steato-hepatite-metabolique-mash-2/ 2025-02-18T14:19:15+00:00 https://groupedevonian.com/devonian-announces-the-filing-of-a-new-patent-application-relating-to-the-use-of-thykaminetm-as-an-antifibrotic-agent/ 2025-02-19T15:16:49+00:00 https://groupedevonian.com/fr/devonian-annonce-le-depot-dune-nouvelle-demande-de-brevet-concernant-lutilisation-du-thykamine-comme-agent-antifibrotique/ 2025-02-19T15:22:42+00:00 https://groupedevonian.com/devonian-reports-results-of-its-annual-general-and-special-meeting-of-shareholders/ 2025-03-24T15:14:32+00:00 https://groupedevonian.com/fr/devonian-annonce-les-resultats-de-son-assemblee-annuelle-generale-et-extraordinaire-des-actionnaires/ 2025-03-24T15:14:50+00:00 https://groupedevonian.com/devonian-reports-delay-of-financial-reporting/ 2025-04-02T14:08:16+00:00 https://groupedevonian.com/fr/devonian-annonce-un-retard-dans-la-publication-des-resultats-financiers/ 2025-04-02T14:08:42+00:00 https://groupedevonian.com/devonian-appoints-new-officers-and-announces-grant-of-stock-options/ 2025-07-03T17:47:32+00:00 https://groupedevonian.com/devonian-health-group-announces-reinstatement-of-quotation-on-the-tsxv/ 2025-07-03T17:47:50+00:00 https://groupedevonian.com/devonian-health-group-reports-second-quarter-2025-financial-results/ 2025-07-03T17:47:59+00:00 https://groupedevonian.com/devonian-health-group-reports-cease-trade-order/ 2025-07-03T17:48:05+00:00 https://groupedevonian.com/devonian-health-group-reports-third-quarter-2025-financial-results/ 2025-07-14T20:08:54+00:00 https://groupedevonian.com/fr/devonian-annonce-la-cloture-dun-placement-prive-dunites-2/ 2025-08-08T14:30:33+00:00 https://groupedevonian.com/devonian-announces-closing-of-a-private-placement-of-units-2/ 2025-08-08T14:36:11+00:00 https://groupedevonian.com/devonian-provides-corporate-update-and-additional-information-regarding-its-previously-announced-private-placement/ 2025-08-22T20:10:28+00:00 https://groupedevonian.com/fr/devonian-publie-une-mise-a-jour-corporative-et-un-complement-dinformation-sur-son-placement-prive-prealablement-annonce/ 2025-08-22T20:10:28+00:00 https://groupedevonian.com/fr/devonian-nomme-de-nouveaux-dirigeants-et-annonce-loctroi-doptions-dachat-dactions/ 2025-09-02T18:21:21+00:00 https://groupedevonian.com/devonian-health-group-inc-announces-its-participation-to-the-thinkequity-conference-in-new-york-and-closing-of-a-non-brokered-private-placement-of-units/ 2025-10-23T15:56:00+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-inc-annonce-sa-participation-a-la-conference-thinkequity-a-new-york-et-la-cloture-dun-placement-prive-dunites-sans-lentremise-dun-courtier/ 2025-10-23T15:56:00+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-publie-ses-etats-financiers-du-troisieme-trimestre-de-2025/ 2025-11-24T21:38:54+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-annonce-sa-readmission-a-la-cote-de-la-tsxv/ 2025-11-24T21:40:21+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-publie-ses-etats-financiers-du-deuxieme-trimestre-de-2025/ 2025-11-24T21:40:33+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-annonce-la-publication-dune-interdiction-doperations/ 2025-11-24T21:40:52+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-annonce-la-resiliation-dune-entente-de-distribution/ 2025-11-24T21:41:10+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-rapporte-une-puissance-anti-inflammatoire-superieure-du-thykamine-dans-une-etude-comparative-in-vitro/ 2025-11-24T21:41:19+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-publie-ses-etats-financiers-du-premier-trimestre-de-2025-annonce-loctroi-doptions-dachat-dactions/ 2025-11-24T21:41:29+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-publie-ses-etats-financiers-pour-son-deuxieme-trimestre-2024-et-une-mise-a-jour-de-ses-activites/ 2025-11-24T21:41:34+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-publie-ses-etats-financiers-pour-son-troisieme-trimestre-de-2024-une-mise-a-jour-de-ses-activites-et-lengagement-dune-firme-de-relation-aux-investisseurs/ 2025-11-24T21:41:40+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-participera-a-la-serie-de-roadshows-virtuels-non-bridge-de-renmark-a-los-angeles-le-mercredi-26-juin-2024/ 2025-11-24T21:41:55+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-participera-a-la-serie-de-roadshows-virtuels-non-bridge-de-renmark-a-boston-le-mercredi-26-juin-2024/ 2025-11-24T21:42:17+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-participera-a-la-serie-de-roadshows-virtuels-non-bridge-de-renmark-a-chicago-le-mercredi-17-juillet-2024/ 2025-11-24T21:42:27+00:00 https://groupedevonian.com/devonian-health-group-reports-its-fourth-quarter-and-annual-2025-financial-results-and-appointment-of-a-new-board-member/ 2025-11-26T22:42:33+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-inc-presente-ses-resultats-financiers-du-quatrieme-trimestre-et-de-lexercice-2025-et-annonce-la-nomination-dun-nouvel-administrateur/ 2025-12-04T16:18:24+00:00 https://groupedevonian.com/devonian-health-group-announces-publication-of-landmark-study-highlighting-thykamine-as-a-promising-new-anti-inflammatory-agent/ 2025-12-09T16:15:15+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-annonce-la-publication-dune-etude-marquante-mettant-en-lumiere-thykaminemc-comme-nouvel-agent-anti-inflammatoire-prometteur/ 2025-12-09T16:15:40+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-presente-ses-resultats-financiers-pour-le-premier-trimestre-clos-le-31-octobre-2025-et-une-mise-a-jour-de-lentreprise/ 2025-12-12T13:59:39+00:00 https://groupedevonian.com/devonian-health-group-reports-financial-results-of-its-first-quarter-ended-on-october-31-2025-and-provides-corporate-update/ 2025-12-12T13:59:39+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-annonce-loctroi-doptions-dachat-dactions/ 2025-12-19T14:30:19+00:00 https://groupedevonian.com/devonian-health-group-announces-grant-of-stock-options/ 2025-12-19T14:30:19+00:00 https://groupedevonian.com/devonian-announces-share-consolidation-in-further-preparation-for-potential-u-s-listing/ 2026-01-20T14:54:56+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-inc-annonce-un-regroupement-dactions-en-preparation-dune-inscription-potentielle-aux-etats-unis/ 2026-02-02T13:26:24+00:00 https://groupedevonian.com/devonian-appoints-dennis-turpin-as-chief-financial-officer-and-provides-updates-on-stock-options-grant/ 2026-02-02T14:00:27+00:00 https://groupedevonian.com/fr/devonian-nomme-dennis-turpin-au-poste-de-la-direction-financiere-et-annonce-lattribution-doptions-dachat-dactions/ 2026-02-03T14:25:25+00:00 https://groupedevonian.com/fr/devonian-presente-des-resultats-positifs-dans-une-etude-sur-la-fibrose-pulmonaire/ 2026-02-10T14:00:11+00:00 https://groupedevonian.com/devonian-reports-positive-results-in-pulmonary-fibrosis-study/ 2026-02-10T14:00:11+00:00 https://groupedevonian.com/devonian-reports-additional-molecular-data-from-mash-liver-study/ 2026-02-12T14:00:20+00:00 https://groupedevonian.com/fr/devonian-presente-des-donnees-moleculaires-supplementaires-issues-dune-etude-hepatique-sur-la-mash/ 2026-02-12T14:00:20+00:00 https://groupedevonian.com/devonian-advances-thykamine-patent-strategy-with-proprietary-fingerprint-and-robust-manufacturing-controls/ 2026-02-17T14:00:48+00:00 https://groupedevonian.com/fr/devonian-renforce-sa-strategie-de-brevets-pour-thykaminemc-grace-a-une-empreinte-exclusive-et-a-des-controles-de-fabrication-rigoureux/ 2026-02-17T14:00:48+00:00 https://groupedevonian.com/devonian-reports-human-liver-on-a-chip-data-demonstrating-disease-relevant-modulation-of-mash-by-thykamine-with-dose-dependent-anti-fibrotic-and-anti-inflammatory-effects/ 2026-02-19T14:00:33+00:00 https://groupedevonian.com/fr/devonian-presente-des-donnees-obtenues-a-partir-dun-modele-de-foie-humain-sur-puce-demontrant-une-modulation-pertinente-de-la-mash-par-thykaminemc-avec-des-effets-antifibrotiques-et-anti-infla/ 2026-02-19T14:00:33+00:00 https://groupedevonian.com/devonian-health-group-inc-reports-financial-and-operating-results-of-its-three-and-six-months-ended-january-31-2026/ 2026-03-30T21:23:51+00:00 https://groupedevonian.com/fr/groupe-sante-devonian-inc-presente-ses-resultats-financiers-et-operationnels-pour-les-periodes-de-trois-et-six-mois-terminees-le-31-janvier-2026/ 2026-03-30T21:28:50+00:00 https://groupedevonian.com/fr/devonian-annonce-les-resultats-de-son-assemblee-annuelle-et-extraordinaire-des-actionnaires/ 2026-03-31T13:00:00+00:00 https://groupedevonian.com/devonian-reports-results-of-its-annual-general-and-special-meeting-of-shareholders-2/ 2026-03-31T13:00:00+00:00